HBI Deals+Insights / Interviews
Spanish diagnostics and radiotherapy group Atrys Health has gone on an M&A spree since IPOing on Spain's small-cap MAB index in 2016. The market has responded bullishly, now valuing Atrys' shares at around 20x 2019 pro-forma EBITDA. We talk to CFO Jose Maria Huch.





